MyFinsight
Home
About
Contact
trda: the income statement
Download
Download image
Unrealized gain on
marketable securities
$221K
(-83.01%↓ Y/Y)
Total comprehensive
(loss) income
-$43,913K
(-244.93%↓ Y/Y)
Total other
comprehensive income
$221K
(-83.01%↓ Y/Y)
Net (loss) income
-$44,134K
(-214.52%↓ Y/Y)
Interest and other income
$3,571K
(-38.07%↓ Y/Y)
Provision for (benefit
from) income taxes
$654K
(135.16%↑ Y/Y)
(loss) income before
provision for income taxes
-$43,480K
(-173.60%↓ Y/Y)
Total other income
$3,571K
(-38.07%↓ Y/Y)
(loss) income from
operations
-$47,051K
(-117.25%↓ Y/Y)
Collaboration revenue
$1,614K
(-91.75%↓ Y/Y)
Total operating
expenses
$48,665K
(18.04%↑ Y/Y)
General and
administrative
$10,304K
(3.34%↑ Y/Y)
Research and development
$38,361K
(22.73%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Entrada Therapeutics, Inc. (TRDA)
Entrada Therapeutics, Inc. (TRDA)